CryoLogyx

 

CryoLogyx. Founded by Dr. Tom Congdon and Prof. Matt Gibson, CryoLogyx specializes in developing high-quality cryopreservation solutions for cell-based assays in drug discovery. Here are some key points about CryoLogyx:

  • PlateReady™: Cryopreserved cells directly adhered to microplates, ready for assays within 24 hours post-thaw.

  • CryoShield™: Their patented cryopreservation formulation integrates nature-inspired soluble ice nucleators, controlling ice nucleation and mitigating supercooling effects.

  • CustomReady™: Customized cell-banking service tailored to meet specific research needs, ensuring ready-to-use, high-quality cells.

  • Achievements: CryoLogyx has received awards, including the SLAS Europe New Product Award in 2024.

Discover CryoLogyx’s advanced cryopreservation solutions – simply thaw with cell culture medium, and the cells are ready for use within 24 hours post-thaw. If you have any more questions or need further information, feel free to contact us.

 

Learn more:

  

 

 

 

         

Assay Ready Cryopreservation of Hepatocytes

as 2-D Monolayers

 

           

Meet CryoShield™ : Multi Award-winning

Cryopreservation Solutions

 

            

Meet our latest cryopreserved

 

 

 

 

         
PlaqueReadyTM Models    PlateReady™ Assay-Ready Plates   ToxReady TM Plates
       

 

 

 

Watch the videos :

 

 
 

Thaw and Use Master Class 24 Well Edition

 

       

Thaw and Use Master Class - 96 Well Edition

 

       

How to use CryoLogyx Thaw and Test Assay Cells 

 

         

 

website: www.cryologyx.com

 
Cancer cells

Cancer cells

Cancer is a disease characterised by the uncontrolled proliferation of cells, resulting from genetic mutations that disrupt the normal cell cycle. Unlike normal cells, cancer cells lose their ability to respond to signals regulating cell growth and division, and acquire the ability to divide indefinitely. These modified cells multiply uncontrollably, forming tumours that can invade and destroy surrounding tissue. In addition, cancer cells can break away from the original tumour and spread to other parts of the body, a process known as metastasis. Distinctive features of cancer cells include their ability to escape programmed cell death and to induce the formation of new blood vessels to ensure their supply of oxygen and nutrients. These characteristics make cancer a complex and multifactorial disease, requiring an in-depth understanding of its mechanisms in order to develop effective treatment strategies. In short, cancer results from the progressive transformation of normal cells into cancerous cells, which lose their control over growth and division and acquire the ability to metastasise, thereby threatening the health of the body.